Related references
Note: Only part of the references are listed.The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis
Martin Tolar et al.
ALZHEIMERS & DEMENTIA (2020)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges
Victor M. Pulgar
FRONTIERS IN NEUROSCIENCE (2019)
Current Approaches and Future Perspectives for Nanobodies in Stroke Diagnostic and Therapy
Larissa Jank et al.
ANTIBODIES (2019)
Chemical biology tools for probing transcytosis at the blood-brain barrier
Rhiannon Beard et al.
CHEMICAL SCIENCE (2019)
Endosomal trafficking regulates receptor-mediated transcytosis of antibodies across the blood brain barrier
Arsalan S. Haqqani et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system
George Thom et al.
MABS (2018)
Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease
Jean-Francois Ghersi-Egea et al.
ACTA NEUROPATHOLOGICA (2018)
Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26
George Thom et al.
MOLECULAR PHARMACEUTICS (2018)
A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis
Maria Ribecco-Lutkiewicz et al.
SCIENTIFIC REPORTS (2018)
The Cellular Composition and Glia-Neuron Ratio in the Spinal Cord of a Human and a Nonhuman Primate: Comparison With Other Species and Brain Regions
Jami Bahney et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2018)
A New Noncanonical Anionic Peptide That Translocates a Cellular Blood-Brain Barrier Model
Sara Neves-Coelho et al.
MOLECULES (2017)
Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells
Henry D. Herce et al.
NATURE CHEMISTRY (2017)
Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity
Carl I. Webster et al.
PAIN (2017)
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease (vol 281, pg 527, 2016)
Harm J. van de Haar et al.
RADIOLOGY (2017)
Development and Function of the Blood-Brain Barrier in the Context of Metabolic Control
Roberta Haddad-Tovolli et al.
FRONTIERS IN NEUROSCIENCE (2017)
Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology
William M. Pardridge
BIODRUGS (2017)
Delivery of a CD20 transferrin receptor VNAR bispecific antibody to the brain for CNS lymphoma
Frank S. Walsh et al.
CANCER RESEARCH (2017)
Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain
Mayur M. Patel et al.
CNS DRUGS (2017)
Nanobodies as therapeutics: big opportunities for small antibodies
Sophie Steeland et al.
DRUG DISCOVERY TODAY (2016)
CSF, blood-brain barrier, and brain drug delivery
William M. Pardridge
EXPERT OPINION ON DRUG DELIVERY (2016)
Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1
Carl I. Webster et al.
FASEB JOURNAL (2016)
Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets
Tengfei Li et al.
JOURNAL OF CONTROLLED RELEASE (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Flora Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Strategies for transporting nanoparticles across the blood-brain barrier
Tian-Tian Zhang et al.
BIOMATERIALS SCIENCE (2016)
Quantitative fluorescence spectroscopy and flow cytometry analyses of cell-penetrating peptides internalization pathways: optimization, pitfalls, comparison with mass spectrometry quantification
Francoise Illien et al.
SCIENTIFIC REPORTS (2016)
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
Jason M. Lajoie et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody
William M. Pardridge
EXPERT OPINION ON DRUG DELIVERY (2015)
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
Matthias D'Huyvetter et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
A novel platform for engineering blood-brain barrier-crossing bispecific biologics
Graham K. Farrington et al.
FASEB JOURNAL (2014)
Potential candidate camelid antibodies for the treatment of protein-misfolding diseases
Monique Antoinette David et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
Jens Niewoehner et al.
NEURON (2014)
Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in Stroke
Daniel Knowland et al.
NEURON (2014)
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Nanobody: The Magic Bullet for Molecular Imaging?
Rubel Chakravarty et al.
THERANOSTICS (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target
Jens De Vos et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Multiplexed Evaluation of Serum and CSF Pharmacokinetics of Brain-Targeting Single-Domain Antibodies Using a NanoLC-SRM-ILIS Method
Arsalan S. Haqqani et al.
MOLECULAR PHARMACEUTICS (2013)
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
Jessica A. Couch et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Adsorptive-Mediated Brain Delivery Systems
Wei Lu
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging
Tengfei Li et al.
FASEB JOURNAL (2012)
Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging
Boguslaw Tomanek et al.
NEURO-ONCOLOGY (2012)
In Vivo Detection of Amyloid-β Deposits Using Heavy Chain Antibody Fragments in a Transgenic Mouse Model for Alzheimer's Disease
Rob J. A. Nabuurs et al.
PLOS ONE (2012)
Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-infrared Fluorescent Anti-Epidermal Growth Factor Receptor Nanobody
Sabrina Oliveira et al.
MOLECULAR IMAGING (2012)
Insulin-like growth factor binding protein 7 exhibits tumor suppressive and vessel stabilization properties in U87MG and T98G glioblastoma cell lines
Ally Pen et al.
CANCER BIOLOGY & THERAPY (2011)
Small unilamellar vesicles: a platform technology for molecular imaging of brain tumors
Umar Iqbal et al.
NANOTECHNOLOGY (2011)
Differential recognition of vascular and parenchymal beta amyloid deposition
Kim S. Rutgers et al.
NEUROBIOLOGY OF AGING (2011)
TRANSMIGRATION OF BETA AMYLOID SPECIFIC HEAVY CHAIN ANTIBODY FRAGMENTS ACROSS THE IN VITRO BLOOD-BRAIN BARRIER
K. S. Rutgers et al.
NEUROSCIENCE (2011)
Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability
Greg Hussack et al.
PLOS ONE (2011)
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
IGF-1 receptor inhibition by picropodophyllin in medulloblastoma
Sachiko Ohshima-Hosoyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies
U. Iqbal et al.
BRITISH JOURNAL OF CANCER (2010)
Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein
Ruben J. Boado et al.
JOURNAL OF BIOTECHNOLOGY (2010)
The Pharmacokinetics of Cell-Penetrating Peptides
Dikran Sarko et al.
MOLECULAR PHARMACEUTICS (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines
Daryl Rhys Jones et al.
PLOS ONE (2010)
Development of new peptide vectors for the transport of therapeutic across the blood-brain barrier
Reinhard Gabathuler
THERAPEUTIC DELIVERY (2010)
Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies
Claire Perruchini et al.
ACTA NEUROPATHOLOGICA (2009)
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
Cecile Vincke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Camelid immunoglobulins and nanobody technology
S. Muyldermans et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2009)
CNS Delivery Via Adsorptive Transcytosis
Francoise Herve et al.
AAPS JOURNAL (2008)
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
W. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2
Michel Demeule et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-β signaling
A. Pen et al.
ONCOGENE (2008)
Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils
Gernot Habicht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and Aβ fibril disaggregation
Ruben J. Boado et al.
BIOCONJUGATE CHEMISTRY (2007)
The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells
A Abulrob et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada
A Ladogana et al.
NEUROLOGY (2005)
Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis
K Benchenane et al.
CIRCULATION (2005)
Pentamerization of single-domain antibodies from phage libraries: A novel strategy for the rapid generation of high-avidity antibody reagents
JB Zhang et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Single-domain antibody fragments with high conformational stability
M Dumoulin et al.
PROTEIN SCIENCE (2002)
Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway
ZM Qian et al.
PHARMACOLOGICAL REVIEWS (2002)
Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium
A Muruganandam et al.
FASEB JOURNAL (2001)
Share Paper
